Peter Feinberg - 29 Sep 2025 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Issuer symbol
IMRX
Transactions as of
29 Sep 2025
Net transactions value
+$35,900
Form type
4
Filing time
30 Sep 2025, 09:00:58 UTC
Previous filing
23 Jun 2025
Next filing
01 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feinberg Peter Director 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE /s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg 30 Sep 2025 0001870076

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $35,900 +5,000 +3.7% $7.18 141,766 29 Sep 2025 Direct
holding IMRX Class A Common Stock 392,242 29 Sep 2025 General Partner of PF Associates L.P.
holding IMRX Class A Common Stock 476,615 29 Sep 2025 General Partner of PEF LLC.
holding IMRX Class A Common Stock 115,441 29 Sep 2025 General Partner of S4K Investments LLC.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.